NXTG.TA
Price:
$77.5
Market Cap:
$62.82M
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-08-12
Stock Exchange
TLV
Ticker
NXTG.TA
According to Nextage Therapeutics Ltd’s latest financial reports and current stock price. The company's current ROE is 66.86%. This represents a change of 12.09% compared to the average of 59.65% of the last 4 quarters.
The mean historical ROE of Nextage Therapeutics Ltd over the last ten years is 351.91%. The current 66.86% ROE has changed -81.00% with respect to the historical average. Over the past ten years (40 quarters), NXTG.TA's ROE was at its highest in in the June 2019 quarter at 581.30%. The ROE was at its lowest in in the December 2020 quarter at -1075.10%.
Average
351.91%
Median
59.51%
Minimum
-1101.10%
Maximum
3.05%
Discovering the peaks and valleys of Nextage Therapeutics Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.83%
Maximum Annual ROE = 3.05%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -1101.10%
| Year | ROE | Change |
|---|---|---|
| 2024 | 59.51% | -55.51% |
| 2023 | 133.76% | -80.00% |
| 2022 | 668.72% | -78.11% |
| 2021 | 3.05% | -377.41% |
| 2020 | -1101.10% | 1.83% |
| 2019 | -57.00% | -110.60% |
| 2018 | 537.54% | -517.41% |
| 2017 | -128.78% | -Infinity% |
The current ROE of Nextage Therapeutics Ltd (NXTG.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
287.33%
5-year avg
563.08%
10-year avg
351.91%
Nextage Therapeutics Ltd’s ROE is greater than Elbit Imaging Ltd. (-13.38%), greater than Endymed Ltd (-11.29%), greater than Canzon Israel Ltd (-72.80%), less than Cannassure Therapeutics Ltd (0%), greater than Erika B-Cure Laser Ltd (-81.20%), greater than Almeda Ventures Limited Partnership (-18.98%), less than Nextgen Biomed Ltd (182.79%), greater than Human Xtensions Ltd. (-158.32%), greater than Erech Finance Cahalacha Ltd (-152.45%), greater than ENvizion Medical Ltd. (-542.01%),
| Company | ROE | Market cap |
|---|---|---|
| -13.38% | $68.37M | |
| -11.29% | $44.05M | |
| -72.80% | $6.51M | |
| 0% | $22.10M | |
| -81.20% | $17.50M | |
| -18.98% | $28.52M | |
| 182.79% | $5.68M | |
| -158.32% | $7.89M | |
| -152.45% | $6.79M | |
| -542.01% | $139.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nextage Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nextage Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nextage Therapeutics Ltd's ROE?
How is the ROE calculated for Nextage Therapeutics Ltd (NXTG.TA)?
What is the highest ROE for Nextage Therapeutics Ltd (NXTG.TA)?
What is the 3-year average ROE for Nextage Therapeutics Ltd (NXTG.TA)?
What is the 5-year average ROE for Nextage Therapeutics Ltd (NXTG.TA)?
How does the current ROE for Nextage Therapeutics Ltd (NXTG.TA) compare to its historical average?